Lumos Diagnostics jumps 18% on US reimbursement wins for FebriDx, its rapid test that distinguishes bacterial vs non-bacterial respiratory infections. Don't miss out on the headlines from Stockhead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback